Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Segulah Medical Acceleration AB
AB
Active
Org 5592384746
Riddargatan 13 K, 114 51
Stockholm
Other financial service activities, except insurance and pension funding n.e.c.
· NACE 6499
Est. 2020
0 employees
Watchlist
Share
Sweden
/
Companies
/
Other financial service activities, except insurance and pension funding n.e.c.
/
Segulah Medical Acceleration AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (4)
BM
Bo Magnus Svensson Henryson
Chief Auditor
Chief Auditor
2026
ME
Maria Elisabet Tell
External Signatory
External Signatory
2021
AS
A Susanna L Francke Rodau
Chief Executive Officer
Chief Executive Officer
2025
UE
Ulrika Elisabeth Wedén
External Signatory
External Signatory
2024
Former (1)
RS
Reita Seseri
Chief Auditor
Chief Auditor
2025 – 2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (6)
AF
Angelika Fatouros
Board of Directors
2024
CA
Claes Agne Ekström
Chairman
2024
LP
Lars Peter Axelsson
Deputy Board Member
2020
GB
Gabriel Bo Urwitz
Board of Directors
2021
AB
Anna Britta Maria Wallgren
Board of Directors
2025
ME
Mikael Elias Kamras
Board of Directors
2021
Former (7)
HJ
Hans Jarl Rutger Arnhult
Deputy Board Member
2020 – 2020
BD
Bo Daniel Falk
Deputy Board Member
2020 – 2020
LA
Lars Anders Larsson
Board of Directors
2020 – 2020
JR
James Roger Gunnarsson
Board of Directors
2022 – 2024
PM
Pia Monica Henriksson Renaudin
Board of Directors
2021 – 2025
BJ
Bo Jesper Daniel Ottergren
Board of Directors
2020 – 2020
MN
Mattias Nickolaus Andreas Schömer
Deputy Board Member
2020 – 2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Segulah Medical Acceleration AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
